Matthew Vincent Dolan - Mar 12, 2024 Form 4 Insider Report for DEXCOM INC (DXCM)

Signature
By: /s/ Jereme M Sylvain For: Matthew Vincent Dolan
Stock symbol
DXCM
Transactions as of
Mar 12, 2024
Transactions value $
-$901,896
Form type
4
Date filed
3/14/2024, 05:39 PM
Previous filing
Mar 11, 2024
Next filing
Mar 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Sale -$902K -6.71K -12.14% $134.41 48.6K Mar 12, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2 Included in this number are 40,075 unvested restricted stock units, 21,711 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 14,512 of which were granted on March 8, 2023 and shall vest through March 8, 2026, and 3,852 of which were granted on March 8, 2022 and shall vest through March 8, 2025.